Protalix BioTherapeutics (PLX) Tops Q1 EPS by 3c, Revenues Beat

Go back to Protalix BioTherapeutics (PLX) Tops Q1 EPS by 3c, Revenues Beat
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 1.54 +0.03 (1.99%)
Previous Close $1.51    52 Week High $1.11 
Open $1.54    52 Week Low $0.41 
Day High $1.58    P/E N/A 
Day Low $1.53    EPS $-0.29 
Volume 422,984